FGF21 and obesity due to melanocortin 4 receptor deficiency: Thus, further investigations are needed to elucidate the molecular mechanisms of FGF21 on bone, particularly as FGF21 analogues/mimetics for the treatment of obesity-related metabolic complications are in various phases of clinical trials.